Per a reader tip, something to be aware of...more information at the site...with video explaining...patients with kidney problems appear to be more at risk...BD
An MRI scan is performed to take a clear detailed picture of a patient's internal organs and tissue and an MRA is used to take a detailed picture of a patient's blood vessels. During some MRI scans and all MRA scans, a gadolinium-based contrast agent is injected into the patient's vein so blood vessels can be distinguished from other nearby tissues. The Food and Drug Administration (FDA) issued a second Public Health Advisory in December 2006 about a new skin disorder known as Nephrogenic Systemic Fibrosis or Nephrogenic Fibrosing Dermotherapy (NSF/NFD). The disease is debilitating and may cause death.
Currently, little is known about NSF/NFD. However, due to recent studies, the association is so strong, that both the FDA and the company that makes gadodiamide have sent out warnings about the use of gadolinium-containing contrast in patients with advanced kidney disease.
Source: Reader Tip